Signage of Biogen facility in Cambridge highlights Alzheimer's drug news - Global Banking & Finance Review
The image features a Biogen facility sign in Cambridge, reflecting the slower-than-expected uptake of its new Alzheimer's drug. This highlights the challenges faced in the pharmaceutical market, particularly in the context of financial implications for Biogen.
Top Stories

Biogen says uptake on new Alzheimer’s drug slower than expected

Related Articles

More from Top Stories

Explore more articles in the Top Stories category